Observational studyEuropean journal of hospital pharmacy : science and practice2020

Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.

Luis Margusino-Framiñán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.